FIELD: medicine.
SUBSTANCE: claimed invention relates to solid dosed compositions containing conjugated estrogens and bazedoxifene or bazedoxifene acetate. In accordance with some versions of invention realisation, said compositions contain core, which contains conjugated estrogens, and at least one envelope, which contains bazedoxifene or bazedoxifene acetate.
EFFECT: solid dosed composition in accordance with invention is intended for treatment of postmenopause symptoms and states with minimisation of proliferative effects in uterus and mammary gland.
52 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING BAZEDOXIFENE ACETATE | 2006 |
|
RU2417084C2 |
| BAZEDOXIFENE TREATMENT SCHEDULE | 2003 |
|
RU2355397C2 |
| COMPOSITION CONTAINING SOLID DISPERSION OF BAZEDOXIFENE ACETATE | 2005 |
|
RU2400227C2 |
| SUGAR COATINGS AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2428178C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING THIAGABIN HYDROCHLORIDE | 1996 |
|
RU2173996C2 |
| SUGAR-BASE COMPOSITION FOR APPLYING ON TABLET, PRESSED TABLET | 1996 |
|
RU2152207C1 |
| PERORAL DOSED COMPOSITION OF PROLONGED ACTION | 2000 |
|
RU2284182C9 |
| GALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2017 |
|
RU2773029C2 |
| SOLID OR SEMI-LIQUID TIME-RELEASE DOSAGE FORMS | 2008 |
|
RU2471480C2 |
| TABLET WITH ENTEROSOLUBLE COATING AND METHOD OF PREPARING | 1998 |
|
RU2201217C2 |
